Apr 24, 2017

Health and quality of life in the company

  • The researcher will represent SEAT at national and international health forums and will collaborate with the company’s medical team
  • Clotet will also be an honorary member of the new Healthy Company Scientific Committee which SEAT will constitute to conduct research into health, well-being and quality of life
  • SEAT is committed to the health of its workers and society at large

Martorell, 24/04/2017. – Dr. Bonaventura Clotet (Barcelona, 1953), world medical authority and chairman of the Fight AIDS Foundation, has been named SEAT Ambassador to strengthen the company’s position as a healthy company. He will also be an honorary member of the new Healthy Company Scientific Committee which the company is going to constitute to conduct research into health, well-being and quality of life. The acclaimed researcher and the company share a commitment to innovation and their ties to Barcelona.

Dr. Clotet is a worldwide reference in the field of HIV research. He is the head of Infectious Diseases Department of the University Hospital Germans Trias I Pujol in Badalona (Barcelona), co-director of the HIV research vaccine program (HIVACAT) and holds several prominent academic positions in the most important Spanish universities.

With this collaboration, SEAT strengthens its commitment to the health of its workers and of society at large. The company provides its 14,500 employees with advanced medical care, which is increasingly focussed on prevention and improving quality of life.

In addition, SEAT also collaborates with health-related institutions, such as the Fight AIDS Foundation and the Spanish Cancer Association (AECC), as part of its Corporate Social Responsibility (CSR).

In his role as ambassador, Dr. Clotet will represent SEAT at several national and international health related forums and will collaborate with the company’s medical team in research into cellular aging, healthy nutrition and the relationship between health and the intestinal microbiome, among others. He will also help SEAT to constitute the Healthy Company Scientific Committee, which will hold its first meeting at the end of May.

In addition, to strengthen his ties to SEAT, Dr. Clotet will be driving an Ateca, the first ever SUV of the Martorell based brand.

SEAT Executive Vice-President for Human Resources Xavier Ros underscored that “we are flattered by the positive cooperation with Dr. Bonaventura Clotet, and it is a privilege to have him as Brand Ambassador. This is another way for SEAT to continue strengthening its social role and the company’s commitment to the health of its employees”.

Furthermore, Dr. Clotet pointed out that “SEAT sets an example to follow for other big companies. The company has a world-class preventive medicine unit geared towards improving the quality of life of its employees. This is the future of occupational health”.

- END -

SEAT is the only company that designs, develops, manufactures and markets cars in Spain. A member of the Volkswagen Group, the multinational has its headquarters in Martorell (Barcelona), exporting 81% of its vehicles, and is present in over 80 countries through a network of 1,700 dealerships. In 2016, SEAT obtained an operating profit of 143 million euros, the highest in the history of the brand, and achieved worldwide sales of nearly 410,000 vehicles.

SEAT Group employs more than 14,500 professionals at its three production centres – Barcelona, El Prat de Llobregat and Martorell, where it manufactures the highly successful Ibiza and Leon. Additionally, the company produces the Ateca and the Toledo in the Czech Republic, the Alhambra in Portugal and the Mii in Slovakia. 

The multinational has a Technical Centre, which operates as a knowledge hub that brings together 1,000 engineers who are focussed on developing innovation for Spain’s largest industrial investor in R&D. SEAT already features the latest connectivity technology in its vehicle range and is currently engaged in the company’s global digitalisation process to promote the mobility of the future.